Deloitte has enhanced its expertise in public health surveillance by acquiring CasePointer, the disease surveillance business of End Point, a move aimed at enhancing its service offerings to government clients. This acquisition brings Deloitte a team of seasoned David Betts, principal at Deloitte Consulting and leader of Deloitte's public health transformation, emphasized the strategic significance of integrating CasePointer's capabilities. The acquisition strengthens Deloitte's ability to support public health agencies in identifying, investigating, and mitigating communicable diseases, environmental hazards, and bioterrorism threats, thereby enhancing emergency response efforts nationwide. Lindsay Hough, another principal at Deloitte Consulting LLP, highlighted the innovative potential of CasePointer's software in improving disease reporting, case investigation, and outbreak management for state and local health authorities. Deloitte's acquisition underscores its commitment to expanding into new markets and reinforcing America's public health infrastructure through advanced technologies, tailored to meet community-specific needs.
Deloitte Expands Public Health Capabilities with Acquisition of CasePointer from End Point
software engineers, cloud developers, DevOps engineers, epidemiologists, and former public health officials. In line with Deloitte's GovConnectTM digital assets, CasePointer specializes in EpiTrax, an open-source platform essential for collecting and organizing epidemiological data.